HKSE - Delayed Quote HKD
Gaush Meditech Ltd (2407.HK)
As of 10:26 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,406,238.000
1,406,238.000
1,253,785.000
1,298,218.000
962,075.000
Cost of Revenue
714,638.000
714,638.000
628,447.000
688,747.000
525,898.000
Gross Profit
691,600.000
691,600.000
625,338.000
609,471.000
436,177.000
Operating Expense
412,445.000
412,445.000
360,529.000
330,590.000
235,243.000
Operating Income
279,155.000
279,155.000
264,809.000
278,881.000
200,934.000
Net Non Operating Interest Income Expense
-44,027.000
-44,027.000
-38,007.000
-81,505.000
-8,295.000
Pretax Income
247,735.000
247,735.000
-275,094.000
-137,964.000
149,155.000
Tax Provision
74,821.000
74,821.000
77,618.000
53,607.000
50,617.000
Net Income Common Stockholders
173,523.000
173,523.000
-349,619.000
-190,447.000
99,367.000
Diluted NI Available to Com Stockholders
173,523.000
173,523.000
-349,619.000
-190,447.000
99,367.000
Basic EPS
1.17
1.17
-3.61
-1.99
0.67
Diluted EPS
1.17
1.17
-3.61
-1.99
0.67
Basic Average Shares
147,969.591
147,969.591
96,947.859
95,840.830
147,934.869
Diluted Average Shares
148,028.666
148,028.666
96,947.859
95,840.830
147,934.869
Total Expenses
1,127,083.000
1,127,083.000
988,976.000
1,019,337.000
761,141.000
Net Income from Continuing & Discontinued Operation
173,523.000
173,523.000
-349,619.000
-190,447.000
99,367.000
Normalized Income
170,615.915
170,615.915
-119,054.000
91,188.500
140,562.629
Interest Income
6,579.000
6,579.000
4,675.000
2,020.000
3,128.000
Interest Expense
50,606.000
50,606.000
42,682.000
83,525.000
3,076.000
Net Interest Income
-44,027.000
-44,027.000
-38,007.000
-81,505.000
-8,295.000
EBIT
298,341.000
298,341.000
-232,412.000
-54,439.000
152,231.000
EBITDA
374,308.000
374,308.000
-166,664.000
5,621.000
164,564.000
Reconciled Cost of Revenue
714,638.000
714,638.000
628,447.000
688,747.000
525,898.000
Reconciled Depreciation
75,967.000
75,967.000
65,748.000
60,060.000
12,333.000
Net Income from Continuing Operation Net Minority Interest
173,523.000
173,523.000
-349,619.000
-190,447.000
99,367.000
Total Unusual Items Excluding Goodwill
4,165.000
4,165.000
-307,420.000
-375,514.000
-62,357.000
Total Unusual Items
4,165.000
4,165.000
-307,420.000
-375,514.000
-62,357.000
Normalized EBITDA
370,143.000
370,143.000
140,756.000
381,135.000
226,921.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
1,257.915
1,257.915
-76,855.000
-93,878.500
-21,161.371
12/31/2020 - 12/12/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade